 The goal of this trial is to evaluate patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography CT or magnetic resonance imaging MRI. 68Ga-PSMA PETCT imaging may help identify potential sites of prostate cancer recurrence for subsequent histologic confirmation. Suspected prostate recurrence will be based upon elevated blood prostate specific antigen PSA levels following initial therapy. 